TrialInvestigational new drugs2011

A pilot phase II trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer.

Margarette Bryan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.